Protara Therapeutics, Inc.
USD4.34
-0.18 (-3.98%)
CEO
Jesse Shefferman
IPO Date
2014-10-22
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$4.47
Prev. Close
$4.52
Day Low
$4.31
Day High
$4.48
52W Low
$2.77
52W High
$7.82
Market Cap
$0.17B
Volume
0.51M
| 22,598 |
| $5.26 |
| 27 Jan 2026 | Fry Hannah | VP, Controller | F-InKind | Disposed | 1,457 | $6.67 |
| 27 Jan 2026 | Fabbio Patrick | Chief Financial Officer | F-InKind | Disposed | 3,261 | $6.67 |
| 27 Jan 2026 | Shefferman Jesse | director, officer: CEO and President | F-InKind | Disposed | 8,732 | $6.67 |
| 27 Jan 2026 | Zummo Jacqueline | Chf Scientific Operations Off | F-InKind | Disposed | 3,724 | $6.67 |
| 22 Jan 2026 | Shefferman Jesse | director, officer: CEO and President | F-InKind | Disposed | 16,322 | $5.60 |
| 22 Jan 2026 | Fabbio Patrick | Chief Financial Officer | F-InKind | Disposed | 3,063 | $5.60 |
| 22 Jan 2026 | Zummo Jacqueline | Chf Scientific Operations Off | F-InKind | Disposed | 6,578 | $5.60 |
| 22 Jan 2026 | Fry Hannah | VP, Controller | F-InKind | Disposed | 2,132 | $5.60 |